ctrl K

Watchlist Price Alert

AEON Biopharma Inc. (AEON)

NASDAQ: AEON · Real-Time Price · USD

0.47

0.01 (2.62%)

At close: May 09, 2025, 12:31 PM

AEON Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	2.52M	3.36M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	1K
Gross Profit	n/a	n/a	n/a	n/a	2.52M	3.36M
Operating Income	72.98M	n/a	-48.43M	-65.85M	-16.39M	-53.97M
Interest Income	n/a	n/a	n/a	n/a	n/a	720K
Pretax Income	42.01M	n/a	-52.56M	-55.64M	-32.91M	145.67M
Net Income	42.01M	n/a	-52.56M	-55.64M	-32.91M	172.92M
Selling & General & Admin	13.64M	n/a	13.68M	11.15M	11.59M	46.04M
Research & Development	14.18M	n/a	34.75M	25.73M	7.32M	4.81M
Other Expenses	-100.81M	n/a	n/a	10.21M	-5.61M	-10.75M
Operating Expenses	-72.98M	n/a	48.43M	36.88M	18.91M	51.73M
Interest Expense	n/a	n/a	n/a	n/a	15K	7.47M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-72.98M	n/a	48.43M	36.88M	18.91M	51.73M
Income Tax Expense	n/a	n/a	n/a	28.97M	15K	-14.64M
Shares Outstanding (Basic)	7.5K	516.11K	305.5K	305.5K	14.8M	14.8M
Shares Outstanding (Diluted)	8K	516.11K	305.5K	305.5K	14.8M	14.8M
EPS (Basic)	5.6K	n/a	-172.03	-182.12	-1.85	11.69
EPS (Diluted)	5.25K	n/a	-172.03	-182.12	-1.85	11.69
EBITDA	-27.73M	n/a	-48.36M	-7.91M	-22.14M	-50.41M
EBIT	-27.82M	n/a	-48.43M	n/a	-32.9M	153.14M
Depreciation & Amortization	97K	n/a	68K	3K	-5.75M	1.26M